Login
$MGNX
$2.14 -$0.03 (1.38%) After hours

$MGNX 3 SEC Filings

Filed On Filing
03 Nov 2026 Form 3: Vasconcelles Michael, Director

No securities owned

03 Nov 2026 Form 3: Kuriakose Emil, Director

No securities owned

13 Jan 2025 Form 3: Smith Beth Ann, VP, Controller & Treasurer

Holds 7,889 shares of Common Stock

05 Jan 2023 Form 3: Chhabra Meenu, Director

No securities owned

05 Jan 2023 Form 3: Liu Margaret, Director

No securities owned

24 May 2022 Form 3: Heiden William K, Director

No securities owned

11 Jun 2021 Form 3: Biotech Target N V, 10% owner and 1 other

Holds 6,025,564 shares of Common Stock

12 Feb 2021 Form 3: O'Brien Federica F., Director

No securities owned

06 Jul 2020 Form 3: Eck Stephen L., Chief Medical Officer

No securities owned

03 Jul 2018 Form 3: Macrogenics Inc, 10% owner · Provention Bio, Inc.
15 Nov 2017 Form 3: Siegel Jay Philip, Director

No securities owned

22 May 2017 Form 3: Peters Jeffrey Stuart, Acting General Counsel
25 Jan 2017 Form 3: Ferrante Karen Jean, Director

No securities owned

25 Jan 2017 Form 3: Jackson Scott Thomas, Director

No securities owned

27 May 2016 Form 3: Spitznagel Thomas, Vice President, Development
09 Jun 2014 Form 3: Saran Atul, See Remarks

Holds 22,500 shares of Common Stock

07 Mar 2014 Form 3: Fust Matthew K, Director

Holds 500 shares of Common Stock

09 Oct 2013 Form 3: Tpg Group Holdings (SBS) Advisors, Inc., 10% owner and 2 others
09 Oct 2013 Form 3: Stump David C, Director

No securities owned

09 Oct 2013 Form 3: Koenig Scott, Director

Holds 53,265 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support